Turkmenistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Turkmenistan Health News.

Press releases published on August 12, 2026

Aug. 12, 2026

TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

Kamada Announces Planned Transition of Chief Financial Officer

Indeterminate GlobeNewswire

Aug. 12, 2026

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer

Indeterminate GlobeNewswire

Aug. 12, 2026

Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

Indeterminate GlobeNewswire

Aug. 12, 2026

Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics

Indeterminate GlobeNewswire

Aug. 12, 2026

Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

Indeterminate GlobeNewswire

Aug. 12, 2026

Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones

Indeterminate GlobeNewswire

Aug. 12, 2026

Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study

Indeterminate GlobeNewswire

Aug. 12, 2026

Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases

Indeterminate GlobeNewswire

Aug. 12, 2026

Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement

Indeterminate GlobeNewswire

Aug. 12, 2026

ダーク・ホース・コンサルティング・グループが中国に進出、カン・リウをシニアディレクター兼中国事業責任者に任命

Indeterminate GlobeNewswire

Aug. 12, 2026

다크호스 컨설팅 그룹, 중국 시장 진출하며 강 리우 중국사업 총괄 수석이사 선임

Indeterminate GlobeNewswire

Aug. 12, 2026

Dark Horse Consulting Group Meluaskan Operasi ke China, Melantik Kang Liu sebagai Pengarah Kanan dan Ketua China

Indeterminate GlobeNewswire

Aug. 12, 2026

Dark Horse Consulting Group 进军中国市场，任命 Kang Liu 为高级总监兼中国区负责人

Indeterminate GlobeNewswire

Aug. 12, 2026

Dark Horse Consulting Group 拓展中國市場，任命 Kang Liu 為高級總監兼中國區負責人

Indeterminate GlobeNewswire

Aug. 12, 2026

FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares

Indeterminate GlobeNewswire